Skip to main content

Table 1 Clinicopathological correlation of the expression of miR-141 in an ovarian cancer tissue array (OVC1021). The 5-fold cut-off was determined by ROC analysis

From: MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis

Parameters

n(=97)

miR-141 expression

≤5-fold

>5-fold

p

Grade

 Low (1 + 2)

50

24 (48%)

26 (52%)

 

 High (3)

46

24 (52%)

22 (48%)

0.838

Stage

 Early (1)

48

31 (65%)

17 (35%)

 

 Late (2 + 3)

49

18 (37%)

31 (63%)

0.008*

Metastasis

 Yes

24

5 (21%)

19 (79%)

 

 No

73

44 (62%)

29 (38%)

0.001*

  1. *P < 0.05